Performance and patients' satisfaction with the A7+TouchCare insulin patch pump system: A randomized controlled...

Area of Science:

• Endocrinology
• Medical Devices
• Diabetes Management

Background:

• A new insulin patch pump, the A7+TouchCare (Medtrum), was evaluated against the established Omnipod system.
• Assessing performance and patient satisfaction are key for new diabetes management technologies.

Purpose of the Study:

• To compare the efficacy and patient satisfaction of the A7+TouchCare insulin patch pump versus the Omnipod system.
• To determine non-inferiority in glucose management between the two insulin pump systems.

Main Methods:

• A multicenter, randomized, open-label, controlled study involving 100 adult patients with type 1 or type 2 diabetes.
• Patients used either the Omnipod or A7+TouchCare pump for 3 months, with glucose management indicator (GMI) from continuous glucose monitoring (CGM) as the primary outcome.

Main Results:

• Non-inferiority in GMI was demonstrated, with a mean difference of 0.002% between the A7+TouchCare and Omnipod groups.
• No significant differences were observed in CGM parameters between the two insulin pump systems.
• Patient satisfaction was high for both systems, though preferences varied for specific features like the patch delivery and control interface.

Conclusions:

• The A7+TouchCare insulin pump is as effective as the Omnipod pump regarding glycemic control and patient satisfaction.
• Both insulin patch pump systems provide viable options for diabetes management, with user interface preferences influencing device choice.